Relocation expenses may be approved for the selectee. NIH employees are subject to Federal government-wide regulations and statutes, as well as agency-specific regulations described at the NIH Ethics Website. We encourage you to review this information. The position is subject to a background investigation and requires the incumbent to complete a public financial disclosure report prior to the effective date of the appointment. We will only accept the completed foreign education evaluation.
Verification must be received prior to the effective date of the appointment. If you require reasonable accommodations during any part of the application and hiring process, please notify us. The decision on granting reasonable accommodation will be made on a case-by-case basis.
Skip to main content. Nurturing the Next Generation of Clinical Researchers. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Standard dates. Conformance to all requirements both in the Application Guide and the FOA is required and strictly enforced. Applicants must read and follow all application instructions in the Application Guide as well as any program-specific instructions noted in Section IV. When the program-specific instructions deviate from those in the Application Guide, follow the program-specific instructions.
Applications that do not comply with these instructions may be delayed or not accepted for review. There are several options available to submit your application through Grants. You must use one of these submission options to access the application forms for this opportunity. Part 1. Overview Information Part 2. Full Text of the Announcement. Section I. Eligibility Information Section IV. Application and Submission Information Section V.
Other Information. The National Heart, Lung, and Blood Institute NHLBI Program Project Grant P01 supports research related to fundamental processes and diseases of the heart, blood and lymphatic vessels, lungs, and blood, including transfusion medicine, blood resources, and sleep disorders and other programs including implementation science, health disparities, and translation research that address the mission of the Institute.
This FOA requires a minimum of three interrelated research projects that investigate a complex biomedical theme or research question. The projects may be supported by scientific cores, if justified, to facilitate economy of effort, space, and equipment. The NHLBI provides support for Program Project Grants PPGs in the belief that collaborative research efforts can accelerate the acquisition of knowledge more effectively than a simple aggregate of research projects that have no interaction or thematic integration.
Use of the P01 mechanism is viewed as an opportunity to attract and include scientists who traditionally have not been supported by the NHLBI. Further, the PPG environment presents an opportunity for emerging scientific leaders to gain insight into how to lead a successful scientific program, and applicants will have the opportunity to include a project led by an Early Stage Investigator ESI.
All projects in the Program must be interrelated and have objectives that address a central theme within the scientific mandate of the NHLBI. The purpose of the Program Project approach is to support integrated, collaborative research programs that have a well-defined, central research focus or objective.
Applications must include a minimum of three individual research projects that contribute to the Program objective. Since the NHLBI is interested in supporting new, innovative research through the Program Project, no more than half of the Projects included in a funded Program Project Grant application may include Projects that significantly overlap in time and objectives with currently funded individual research project grants, i.
Each individual research Project should reflect a distinct, separate, scientifically meritorious research effort led by an independent investigator, the Project Leader. In addition, the individual Projects should be clearly interrelated and synergistic so that the research ideas, efforts, and outcomes of the Program as a whole will offer a distinct advantage over pursuing the individual projects separately. In addition to individual research Projects, applicants may propose an Administrative Core and one or more shared Scientific Core s as necessary to facilitate the proposed research Projects.
It is expected that each Scientific Core will be utilized by two or more Projects within the Program. Any proposed Scientific Core, if justified, is expected to be considered essential to conduct the Program and should not duplicate existing institutional resources.
Please refer to the FAQ page for additional guidance. Applications not responsive to this FOA will not be reviewed. Other Information for award authorities and regulations. Grant: A support mechanism providing money, property, or both to an eligible entity to carry out an approved project or activity.
Applicants are limited to one renewal Type 2. No renewal Type 2 applications beyond year 10 will be accepted to this FOA. Only those application types listed here are allowed for this FOA. Need help determining whether you are doing a clinical trial? The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications. Project budgets should reflect the actual needs of the proposed project.
No annual increases in noncompeting years may be requested. Facilities and administrative costs requested by first tier consortium participants are not included in the direct cost see NOT-OD However, facilities and administrative costs for second tier consortium are included in the direct cost. Applicants should discuss equipment requests with NHLBI staff early in the planning phase and must receive permission from the Institute to include equipment costs in their budget request.
Equipment is included in the budget ceiling. Final decisions on equipment requests will depend on the nature of the justification and the Institute's fiscal situation. The scope of the proposed program should determine the project period.
The maximum project period is 5 years. Non-domestic non-U. Entities Foreign Institutions are not eligible to apply. Organizations are eligible to apply. All registrations must be completed prior to the application being submitted. Registration can take 6 weeks or more, so applicants should begin the registration process as soon as possible. The NIH Policy on Late Submission of Grant Applications states that failure to complete registrations in advance of a due date is not a valid reason for a late submission.
Obtaining an eRA Commons account can take up to 2 weeks. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. Additionally, Project Leaders are expected to have demonstrated the ability to lead an R01, or Requivalent, grant. Applicant organizations may submit more than one application, provided that each application is scientifically distinct.
The NIH will not accept duplicate or highly overlapping applications under review at the same time. This means that the NIH will not accept:. The application forms package specific to this opportunity must be accessed through ASSIST or an institutional system-to-system solution.
See your administrative office for instructions if you plan to use an institutional system-to-system solution. Conformance to the requirements in the Application Guide is required and strictly enforced. Applications that are out of compliance with these instructions may be delayed or not accepted for review. Although a letter of intent is not required, is not binding, and does not enter into the review of a subsequent application, the information that it contains allows IC staff to estimate the potential review workload and plan the review.
By the date listed in Part 1. Overview Information , prospective applicants are asked to submit a letter of intent that includes the following information:. Note: Human Embryonic Stem Cell lines from other components should be repeated in cell line table in Overall component. A budget summary in the Overall section of the assembled application image in eRA Commons compiled from detailed budget data collected in the other components will be generated upon submission.
Specific Aims: Describe the specific aims for the Overall Program. List the goals of the research and summarize expected outcomes. Research Strategy: Describe the significance, innovation, and approach of the overall application and highlight the Program's conceptual unity by describing the scientific problems to be addressed and laying out a broad research strategy to address them.
The Program Project should be viewed as a group of interrelated research Projects, each of which is not only individually meritorious scientifically but also complementary to and interrelated with the other Projects in the research Program that contribute to the integrating theme.
The theme of a proposed Program Project should be established in the first few sentences of this section. It should include a description of the major research objectives and strategic plan. Explain how the proposed Projects and shared Scientific Cores if proposed and justified will be coordinated and work together to address the overall goals and aims of the Program more effectively than if the Projects were conducted independently.
Describe any prior collaborative arrangements between investigators in the group to explain the genesis of the current application, to predict the anticipated unique advantages that would be gained by the research within the proposed Program Project, to describe how the Projects are interrelated, and to explain how the proposed Program Project would enable the stated objectives of the proposed research to be addressed more efficiently and effectively than a group of individual research project grants.
Summary Report of Progress: For renewal applications only, include a progress report that summarizes the aims and accomplishments of the Program during the prior funding period.
See the SF instructions for details about what to include in the progress report. If a project from the prior funding period is being discontinued, explain in the overall progress report.
A progress report is required for each research Project and Core s in the respective components of the application. Identify each as a "new" or "continuing" component.
In addition, if an Administrative Core is not proposed, applicants must provide the information outlined in the Administrative Core Research Strategy section. Letters of Support: Attach letters of support relevant to the Program as a whole e. Letters of support relevant to specific Projects or Cores should be attached in the relevant Project or Core Research Plan forms. All applications, regardless of the amount of direct costs requested for any one year, should address a Data Sharing Plan.
Only limited items are allowed in the Appendix. The study record s must be included in the component s where the work is being done, unless the same study spans multiple components. To avoid the creation of duplicate study records, a single study record with sufficient information for all involved components must be included in the Overall component when the same study spans multiple components.
Note: Delayed onset does NOT apply to a study that can be described but will not start immediately i. Note: The Project Performance Site form allows up to sites, prior to using additional attachment for additional entries.
Budget forms appropriate for the specific component will be included in the application package. Introduction to Application: For Resubmission applications, an Introduction to Application is allowed for the Administrative Core component. Specific Aims: List in priority order, the broad, long-range objectives and goals of the proposed Administrative Core. Explain the plans for organizational and administrative management of the entire Program, and for coordination and communication within the Program.
Explain the methods that will be used for monitoring progress in the Projects and effective use of the shared Scientific Cores.
Explain the plans for internal quality control of on-going research, management of day-to-day program activities, management of contractual agreements if applicable , and a plan for resolution of disputes.
Indicate where in the chain of responsibility advisory groups internal and external consultants would be used, and describe their function in ensuring quality control in the research efforts. For an External Advisory Board, describe the expertise and responsibilities of your potential Board members. If submitting a new application, do not contact, recruit, or name potential members of the External Advisory Board. New Program Project Grant applications should not constitute an External Advisory Board prior to or during the review of their application because individuals identified in an application cannot participate in its peer review.
Renewal applications should provide the names of current and former members. The External Advisory Board should consist of two or three named advisers committed to the evaluation of the Program. Two or three additional advisers may be added once the progress of the Program and its needs are clearer. The Internal Advisory Board should consist of three to five members outside of the Program but within the applicant institution who are able to assist in frequent, ongoing oversight.
Relation of the Program Project Grant to the Administration of the Applicant Institution : Describe the relationship between the proposed Program Project and other existing research, academic, and administrative units of the applicant institution such as schools, centers, institutions, departments, and central administration.
The DIR is also very involved in conducting concept-based clinical studies in the areas of interventional and surgical cardiology; pulmonary medicine; sickle cell anemia; bone marrow transplant; and hematologic disorders. This program provides opportunities for scientists and trainees to work together towards a better understanding of molecular machines, the cell, the body, and ultimately the treatment of human diseases.
Skip to main content.
0コメント